Compound α-Ketoacid Tablets
Description
- 产品描述
-
Product Information
Product Name: Compound α-Ketoacid Tablets
Specification: 630mg
Ingredients: Composed of calcium DL-α-ketoisoleucinate, calcium α-ketoleucinate, calcium α-ketovalinate and other components.
Description: Yellow film-coated tablets.
Indications: Mainly used as adjuvant therapy for patients with chronic kidney disease (CKD). Especially for patients at stage 3 to 5 on a low-protein diet, it helps improve nutritional status and reduce renal metabolic burden by supplementing essential amino acid analogues.
FAQs
What main products does Baotai Pharmaceutical supply?
Which countries and regions do you mainly export to?
Does your company have international GMP qualification support?
Can you help complete local drug registration in target countries?
What therapeutic areas do your human medicines focus on?
Do you cooperate with formal domestic pharmaceutical manufacturers?
Compound α-Ketoacid Tablets
OUR SERVICE
We offers a wealth of product support resources, including a range of technical and downloadable product manuals to product certifications.
Documentation Contact UsRelated Products
The content is currently being updated……